Glenmark receives USFDA approval for Bisoprolol Fumarate and Hydrochlorothiazide Tablets

29 Jan 2022 , 01:32 AM

Glenmark Pharmaceuticals Inc USA Glenmark has received final approval by the United States Food Drug Administration US FDA for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP 25 mg625 mg 5 mg625 mg and 10 mg625 mg the generic version of Ziac1 Tablets 25 mg625 mg 5 mg625 mg and 10 mg625 mg of Teva Branded Pharmaceutical Products RD Inc According to IQVIAtrade; sales data for the 12 month period ending November 2021 the Ziac Tablets 25 mg625 mg 5 mg625 mg and 10 mg625 mg market achieved annual sales of approximately $303 million